Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010163650> ?p ?o ?g. }
- W2010163650 endingPage "2499" @default.
- W2010163650 startingPage "2489" @default.
- W2010163650 abstract "Abstract The proteasome inhibitor bortezomib is a novel anticancer drug that has shown promise in the treatment of refractory multiple myeloma. However, its clinical efficacy has been hampered by the emergence of drug-resistance phenomena, the molecular basis of which remains elusive. Toward this end, we here developed high levels (45- to 129-fold) of acquired resistance to bortezomib in human myelomonocytic THP1 cells by exposure to stepwise increasing (2.5-200 nM) concentrations of bortezomib. Study of the molecular mechanism of bortezomib resistance in these cells revealed (1) an Ala49Thr mutation residing in a highly conserved bortezomib-binding pocket in the proteasome β5-subunit (PSMB5) protein, (2) a dramatic overexpression (up to 60-fold) of PSMB5 protein but not of other proteasome subunits including PSMB6, PSMB7, and PSMA7, (3) high levels of cross-resistance to β5 subunit-targeted cytotoxic peptides 4A6, MG132, MG262, and ALLN, but not to a broad spectrum of chemotherapeutic drugs, (4) no marked changes in chymotrypsin-like proteasome activity, and (5) restoration of bortezomib sensitivity in bortezomib-resistant cells by siRNA-mediated silencing of PSMB5 gene expression. Collectively, these findings establish a novel mechanism of bortezomib resistance associated with the selective overexpression of a mutant PSMB5 protein." @default.
- W2010163650 created "2016-06-24" @default.
- W2010163650 creator A5003271927 @default.
- W2010163650 creator A5007946879 @default.
- W2010163650 creator A5013852274 @default.
- W2010163650 creator A5015712876 @default.
- W2010163650 creator A5033467261 @default.
- W2010163650 creator A5035296183 @default.
- W2010163650 creator A5043037950 @default.
- W2010163650 creator A5049292621 @default.
- W2010163650 creator A5049432480 @default.
- W2010163650 creator A5059127278 @default.
- W2010163650 creator A5062435332 @default.
- W2010163650 creator A5067029743 @default.
- W2010163650 creator A5070729528 @default.
- W2010163650 creator A5072587294 @default.
- W2010163650 creator A5079186496 @default.
- W2010163650 creator A5085213730 @default.
- W2010163650 creator A5085426388 @default.
- W2010163650 date "2008-09-15" @default.
- W2010163650 modified "2023-10-10" @default.
- W2010163650 title "Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein" @default.
- W2010163650 cites W119139793 @default.
- W2010163650 cites W1485176492 @default.
- W2010163650 cites W1503898156 @default.
- W2010163650 cites W1540671296 @default.
- W2010163650 cites W1556426431 @default.
- W2010163650 cites W1578095196 @default.
- W2010163650 cites W1603251764 @default.
- W2010163650 cites W1963689482 @default.
- W2010163650 cites W1965936894 @default.
- W2010163650 cites W1972920532 @default.
- W2010163650 cites W1974012392 @default.
- W2010163650 cites W1980471295 @default.
- W2010163650 cites W1984678830 @default.
- W2010163650 cites W1984998337 @default.
- W2010163650 cites W1987583882 @default.
- W2010163650 cites W1988166297 @default.
- W2010163650 cites W2011244308 @default.
- W2010163650 cites W2011457559 @default.
- W2010163650 cites W2016742872 @default.
- W2010163650 cites W2019543614 @default.
- W2010163650 cites W2020999109 @default.
- W2010163650 cites W2043943641 @default.
- W2010163650 cites W2044920880 @default.
- W2010163650 cites W2049743082 @default.
- W2010163650 cites W2053728180 @default.
- W2010163650 cites W2055904567 @default.
- W2010163650 cites W2067653691 @default.
- W2010163650 cites W2067882963 @default.
- W2010163650 cites W2068696470 @default.
- W2010163650 cites W2084925682 @default.
- W2010163650 cites W2085431272 @default.
- W2010163650 cites W2088724822 @default.
- W2010163650 cites W2097790679 @default.
- W2010163650 cites W2103185055 @default.
- W2010163650 cites W2105010141 @default.
- W2010163650 cites W2108235071 @default.
- W2010163650 cites W2112190271 @default.
- W2010163650 cites W2113500856 @default.
- W2010163650 cites W2116588376 @default.
- W2010163650 cites W2126267349 @default.
- W2010163650 cites W2134334757 @default.
- W2010163650 cites W2149843709 @default.
- W2010163650 cites W2150123812 @default.
- W2010163650 cites W2163495162 @default.
- W2010163650 cites W2166761147 @default.
- W2010163650 cites W2166987747 @default.
- W2010163650 cites W2167715756 @default.
- W2010163650 cites W2564495232 @default.
- W2010163650 cites W2575351375 @default.
- W2010163650 cites W4237456957 @default.
- W2010163650 cites W4245266060 @default.
- W2010163650 doi "https://doi.org/10.1182/blood-2007-08-104950" @default.
- W2010163650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18565852" @default.
- W2010163650 hasPublicationYear "2008" @default.
- W2010163650 type Work @default.
- W2010163650 sameAs 2010163650 @default.
- W2010163650 citedByCount "395" @default.
- W2010163650 countsByYear W20101636502012 @default.
- W2010163650 countsByYear W20101636502013 @default.
- W2010163650 countsByYear W20101636502014 @default.
- W2010163650 countsByYear W20101636502015 @default.
- W2010163650 countsByYear W20101636502016 @default.
- W2010163650 countsByYear W20101636502017 @default.
- W2010163650 countsByYear W20101636502018 @default.
- W2010163650 countsByYear W20101636502019 @default.
- W2010163650 countsByYear W20101636502020 @default.
- W2010163650 countsByYear W20101636502021 @default.
- W2010163650 countsByYear W20101636502022 @default.
- W2010163650 countsByYear W20101636502023 @default.
- W2010163650 crossrefType "journal-article" @default.
- W2010163650 hasAuthorship W2010163650A5003271927 @default.
- W2010163650 hasAuthorship W2010163650A5007946879 @default.
- W2010163650 hasAuthorship W2010163650A5013852274 @default.
- W2010163650 hasAuthorship W2010163650A5015712876 @default.
- W2010163650 hasAuthorship W2010163650A5033467261 @default.
- W2010163650 hasAuthorship W2010163650A5035296183 @default.